Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener Medizinische Wochenschrift 3-4/2017

01.03.2017 | main topic

Disseminated superficial actinic porokeratosis (DSAP): significant improvement after local administration of calcipotriol/betamethasone gel?

verfasst von: PhD Prof. Dr. Georgi Tchernev, Dr. Anastasiya Atanasova Chokoeva, Dr. Bogdana Ivanova, Dr. Hristo Mangarov, Dr. Nadezhda Georgieva Vidolova

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 3-4/2017

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Porokeratosis is defined as a disorder of keratinization characterized by one or more atrophic patches surrounded by a clinically and histologically distinctive hyperkeratotic ridgelike border called the cornoid lamella. Lesions are most commonly located on the sun-exposed sides of trunk and extremities, while exclusive facial involvement has been also reported. Despite that the exact risk of cutaneous malignancy developing in porokeratosis is unknown, it is confirmed by series of case reports, including squamous cell carcinoma, basal cell carcinoma and even melanoma. Although no definite cure exists, a number of treatment modalities, from topical medications to laser and light devices, have been reported with variable success. Although promising, reports of disseminated superficial actinic porokeratosis treated with vitamin D3 analogs are rare. No satisfactory enough effect is obtained also with calcipotriol monotherapy.
We report a case of disseminated superficial actinic porokeratosis in a 80-year-old female patient, successfully treated with combination of topical calcipotriol/betamethasone gel. A significant improvement was noticed after 3 weeks; almost full resolution of the clinical symptoms without appearance of fresh lesions was achieved in the second month. To the best of our knowledge, this is the first report of successful treatment with full resolution in a short interval, by simultaneous application of vitamin D3 analog (calcipotriol) and corticosteroid (betamethasone), combined in a one commercial product as a gel for treatment of keratinocyte proliferation’s disorder such as psoriasis vulgaris. This promising new entity seems to be more effective, because of the simultaneous synergetic effects of the substations, namely the normalization of the proliferation of the keratinocytes by calcipotriol on one hand, and the reducing of the inflammation by the corticosteroid on another. Sun protection stays always mandatory, as well as the regular clinical observation, regarding the risk of malignant transformation.
Literatur
1.
Zurück zum Zitat Dedhia AR, Someshwar SJ, Jerajani HR. Facial solar porokeratosis. Indian J Dermatol Venereol Leprol. 2016;82(3):337–9. CrossRefPubMed Dedhia AR, Someshwar SJ, Jerajani HR. Facial solar porokeratosis. Indian J Dermatol Venereol Leprol. 2016;82(3):337–9. CrossRefPubMed
2.
Zurück zum Zitat Biswas A. Cornoid lamellation revisited: apropos of porokeratosis with emphasis on unusual clinicopathological variants. Am J Dermatopathol. 2015;37(2):145–55. CrossRefPubMed Biswas A. Cornoid lamellation revisited: apropos of porokeratosis with emphasis on unusual clinicopathological variants. Am J Dermatopathol. 2015;37(2):145–55. CrossRefPubMed
3.
Zurück zum Zitat Trikha R, Wile A, King J, Ward KH, Brodell RT. Punctate follicular porokeratosis: clinical and pathologic features. Am J Dermatopathol. 2015;37(11):e134–e136. CrossRefPubMed Trikha R, Wile A, King J, Ward KH, Brodell RT. Punctate follicular porokeratosis: clinical and pathologic features. Am J Dermatopathol. 2015;37(11):e134–e136. CrossRefPubMed
4.
Zurück zum Zitat Wei SC, Yang S, Li M, Song YX, Zhang XQ, Bu L. Identification of a locus for porokeratosis palmaris et plantaris disseminata to a 6.9-cM region at chromosome 12q24.1-24.2. Br J Dermatol. 2003;149(2):261–7. CrossRefPubMed Wei SC, Yang S, Li M, Song YX, Zhang XQ, Bu L. Identification of a locus for porokeratosis palmaris et plantaris disseminata to a 6.9-cM region at chromosome 12q24.1-24.2. Br J Dermatol. 2003;149(2):261–7. CrossRefPubMed
5.
Zurück zum Zitat Riyaz N. Porokeratosis and malignancy: incidental or causal association? Indian Dermatol Online J. 2015;6(6):452–3. PubMedPubMedCentral Riyaz N. Porokeratosis and malignancy: incidental or causal association? Indian Dermatol Online J. 2015;6(6):452–3. PubMedPubMedCentral
6.
Zurück zum Zitat Breneman DL, Breneman JC. Cutaneous T‑cell lymphoma mimicking porokeratosis of Mibelli. J Am Acad Dermatol. 1993;29:1046–8. CrossRefPubMed Breneman DL, Breneman JC. Cutaneous T‑cell lymphoma mimicking porokeratosis of Mibelli. J Am Acad Dermatol. 1993;29:1046–8. CrossRefPubMed
7.
Zurück zum Zitat Sasson M, Krain AD. Porokeratosis and cutaneous malignancy. A review. Dermatol Surg. 1996;22:339–42. PubMed Sasson M, Krain AD. Porokeratosis and cutaneous malignancy. A review. Dermatol Surg. 1996;22:339–42. PubMed
8.
Zurück zum Zitat Lopes LN, Gouveia AI, Soares-Almeida L, Sacramento-Marques M, Filipe P. Porokeratosis and malignant melanoma: a causal or incidental association? Indian Dermatol Online J. 2015;6(6):451–2. CrossRefPubMedPubMedCentral Lopes LN, Gouveia AI, Soares-Almeida L, Sacramento-Marques M, Filipe P. Porokeratosis and malignant melanoma: a causal or incidental association? Indian Dermatol Online J. 2015;6(6):451–2. CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Garrido-Colmenero C, Ruiz-Villaverde R, Martínez-García E, Aneiros-Fernández J, Tercedor-Sánchez J. Photoletter to the editor: response of linear porokeratosis to photodynamic therapy in an 11-year-old girl. J Dermatol Case Rep. 2015;9(4):118–9. CrossRefPubMedPubMedCentral Garrido-Colmenero C, Ruiz-Villaverde R, Martínez-García E, Aneiros-Fernández J, Tercedor-Sánchez J. Photoletter to the editor: response of linear porokeratosis to photodynamic therapy in an 11-year-old girl. J Dermatol Case Rep. 2015;9(4):118–9. CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Ross NA, Rosenbaum LE, Saedi N, Arndt KA, Dover JS. Disseminated superficial actinic porokeratosis improved with fractional 1927-nm laser treatments. J Cosmet Laser Ther. 2016;18(1):53–5. CrossRefPubMed Ross NA, Rosenbaum LE, Saedi N, Arndt KA, Dover JS. Disseminated superficial actinic porokeratosis improved with fractional 1927-nm laser treatments. J Cosmet Laser Ther. 2016;18(1):53–5. CrossRefPubMed
11.
Zurück zum Zitat Chernosky ME, Freeman RG. Disseminated superficial actinic porokeratosis (DSAP). Arch Dermatol. 1967;96:611–24. CrossRefPubMed Chernosky ME, Freeman RG. Disseminated superficial actinic porokeratosis (DSAP). Arch Dermatol. 1967;96:611–24. CrossRefPubMed
12.
Zurück zum Zitat Nakamura Y, Yamaguchi M, Nakamura A, Muto M. Calcipotriol and adapalene therapy for disseminated superficial actinic porokeratosis. Indian J Dermatol Venereol Leprol. 2014;80:373–4. CrossRefPubMed Nakamura Y, Yamaguchi M, Nakamura A, Muto M. Calcipotriol and adapalene therapy for disseminated superficial actinic porokeratosis. Indian J Dermatol Venereol Leprol. 2014;80:373–4. CrossRefPubMed
13.
Zurück zum Zitat Böhm M, Luger TA, Bonsmann G. Disseminated superficial actinic porokeratosis: treatment with topical tacalcitol. J Am Acad Dermatol. 1999;40(3):479–80. CrossRefPubMed Böhm M, Luger TA, Bonsmann G. Disseminated superficial actinic porokeratosis: treatment with topical tacalcitol. J Am Acad Dermatol. 1999;40(3):479–80. CrossRefPubMed
14.
Zurück zum Zitat Harrison PV, Stollery N. Disseminated superficial actinic porokeratosis responding to calcipotriol. Clin Exp Dermatol. 1994;19:95. CrossRefPubMed Harrison PV, Stollery N. Disseminated superficial actinic porokeratosis responding to calcipotriol. Clin Exp Dermatol. 1994;19:95. CrossRefPubMed
15.
Zurück zum Zitat van de Kerkhof PC. Treatment options in monogenic disorders of keratinization. J Dtsch Dermatol Ges. 2003;1(10):763–4. CrossRefPubMed van de Kerkhof PC. Treatment options in monogenic disorders of keratinization. J Dtsch Dermatol Ges. 2003;1(10):763–4. CrossRefPubMed
16.
Zurück zum Zitat Guarneri C, Cannavò SP, Lentini M, Polimeni G. Adalimumab-induced disseminated superficial porokeratosis. Ann Pharmacother. 2011;45(2):280–1. PubMed Guarneri C, Cannavò SP, Lentini M, Polimeni G. Adalimumab-induced disseminated superficial porokeratosis. Ann Pharmacother. 2011;45(2):280–1. PubMed
Metadaten
Titel
Disseminated superficial actinic porokeratosis (DSAP): significant improvement after local administration of calcipotriol/betamethasone gel?
verfasst von
PhD Prof. Dr. Georgi Tchernev
Dr. Anastasiya Atanasova Chokoeva
Dr. Bogdana Ivanova
Dr. Hristo Mangarov
Dr. Nadezhda Georgieva Vidolova
Publikationsdatum
01.03.2017
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift / Ausgabe 3-4/2017
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-016-0484-8